This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Recognize early warning signs of money trouble in your 20s and take decisive steps to protect your financial future.
22,522 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A 62-year-old with $1.4 million faces a five-year bridge to Social Security. Experts urge planners to treat this as a...
Oil and currency markets tremble as new Iran-related tensions top the global agenda. Asia, with its export-led growth...
A 62-year-old diagnosed with serious illness chooses to take Social Security now rather than wait until 70, highlight...
When a company’s top legal officer discloses a stock sale, investors pay attention. This guide explains how to read i...
A new income strategy is gaining traction among retirees and advisers: a retirement portfolio that forks into dual in...
A pro-Iranian hacking group claims it accessed the personal email of FBI Director Kash Patel, releasing old photos an...
A growing gap between traditional savings rates and high-yield options is letting households miss out on hundreds, ev...
A growing number of high-income workers are using in-plan roth conversion high strategies within 401(K) plans to dodg...
New SSA data show most retirees start Social Security before age 70, missing the strongest move that could boost life...
A retiree who split time between the U.S. and Germany gains a modest U.S. Social Security benefit via totalization. T...
As mortgage rates climb, wealthier borrowers face a stark trade-off: paying off a low-rate loan early may cost them s...